Interní Med. 2009; 11(9): 425-426
When to recommend HPV vaccination to female patients?
- Gynekologicko-porodnická klinika, 2. LF a FN v Motole, Univerzita Karlova v Praze
Currently, human papillomavirus (HPV) infection is considered to be the most common sexually transmitted disease. The lifetime prevalence
of this infection is as much as 80 %. The majority of infected individuals achieve so-called spontaneous clearance of the infection
due to immune mechanisms. The period during which the body clears the HPV infection, the clearance time, is usually between 8 and 24
months. HPV infection is most common in early adulthood between 18 and 25 years of age; it is rarer in later life. In women over 35 years
of age, the infection is diagnosed in only about three to five percent. Vaccination is the most recent and reliable method of prevention
from HPV infection.
Keywords: HPV, cervical cancer, vaccination.
Published: October 1, 2009 Show citation
References
- Markowitz LE, Dunne EF, Saraiya M, et al. Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Reccmm Rep, 2007; 23 (56): 1-24.
Go to original source... - Munoz N, Castellsagne X, de Gonzalez AB, Gissmann L. HPV in the etiology of human cancer. Vaccine, 2006; 24 (S3): 2-10. Go to original source...
Go to PubMed... - Tachezy R. Epidemiologie genitální papilomavirové infekce ve světě a ČR. Moderní gynekologie a porodnictví. Supplementum A, 2006; 15 (4): 589-594.
- Castle PE, Fetterman B, Akhtar I, et al. Age-appropriate use of human papillomavirus vaccines in the U.S. Gynecol Oncol, 2009 May 21. [Epub ahead of print]. Go to original source... Go to PubMed...
- Pluta M. HPV vakcína. Moderní gynekologie a porodnictví. 2006; 15 (4): 609-616.
- Schmiedeskamp MR, Kockler DR. Human papillomavirus vaccines. Ann Pharmacother, 2006; 40: 1344-1352. Go to original source... Go to PubMed...
- Recommended Adult Immunization Schedule - United States, 2009. Morb Mortal Wkly Rep, 2009; 57: 53.